These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria. Svetlov MS; Cohen S; Alsuhebany N; Vázquez-Laslop N; Mankin AS Proc Natl Acad Sci U S A; 2020 Jan; 117(4):1971-1975. PubMed ID: 31932436 [TBL] [Abstract][Full Text] [Related]
9. Macrolide-peptide conjugates as probes of the path of travel of the nascent peptides through the ribosome. Washington AZ; Benicewicz DB; Canzoneri JC; Fagan CE; Mwakwari SC; Maehigashi T; Dunham CM; Oyelere AK ACS Chem Biol; 2014 Nov; 9(11):2621-31. PubMed ID: 25198768 [TBL] [Abstract][Full Text] [Related]
10. Toward the rational design of macrolide antibiotics to combat resistance. Pavlova A; Parks JM; Oyelere AK; Gumbart JC Chem Biol Drug Des; 2017 Nov; 90(5):641-652. PubMed ID: 28419786 [TBL] [Abstract][Full Text] [Related]
11. Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics. Svetlov MS; Vázquez-Laslop N; Mankin AS Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13673-13678. PubMed ID: 29229833 [TBL] [Abstract][Full Text] [Related]
12. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel. Kannan K; Vázquez-Laslop N; Mankin AS Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624 [TBL] [Abstract][Full Text] [Related]
13. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA. Garza-Ramos G; Xiong L; Zhong P; Mankin A J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379 [TBL] [Abstract][Full Text] [Related]
14. Drug interactions of macrolides: emphasis on dirithromycin. Watkins VS; Polk RE; Stotka JL Ann Pharmacother; 1997 Mar; 31(3):349-56. PubMed ID: 9066944 [TBL] [Abstract][Full Text] [Related]
15. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action. Kannan K; Mankin AS Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525 [TBL] [Abstract][Full Text] [Related]
16. Binding site of the bridged macrolides in the Escherichia coli ribosome. Xiong L; Korkhin Y; Mankin AS Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307 [TBL] [Abstract][Full Text] [Related]
17. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study. Nguyen HL; An PH; Thai NQ; Linh HQ; Li MS J Mol Graph Model; 2019 Sep; 91():80-90. PubMed ID: 31200217 [TBL] [Abstract][Full Text] [Related]
18. Context-specific action of macrolide antibiotics on the eukaryotic ribosome. Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576 [TBL] [Abstract][Full Text] [Related]
19. Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22. Moore SD; Sauer RT Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18261-6. PubMed ID: 19015512 [TBL] [Abstract][Full Text] [Related]
20. Macrolide antibiotics allosterically predispose the ribosome for translation arrest. Sothiselvam S; Liu B; Han W; Ramu H; Klepacki D; Atkinson GC; Brauer A; Remm M; Tenson T; Schulten K; Vázquez-Laslop N; Mankin AS Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9804-9. PubMed ID: 24961372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]